Halozyme Therapeutics, Inc. (HALO) Earnings Calendar & Upcoming Events

Halozyme Therapeutics, Inc. (HALO) — Price $106.99 HealthcareBiotechnology — NASDAQ

Latest reported results:

Corporate calendar for Halozyme Therapeutics, Inc. (HALO): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.

Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform, which utilizes a patented recombinant human hyaluronidase enzyme (rHuPH20).

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-09-15
2026-09-15
2026-09-15
2026-09-15
2026-09-15
2026-09-15$344M

Price

Price$106.99
Market Cap$12.7B
ExchangeNASDAQ
CountryUS

Related companies: ABVX · ATR · CAI · CORT · CYTK · GRFS · HSIC

Explore sector: Healthcare · Biotechnology

More sections of HALO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks